Tirzepatide for alcohol use disorder
Treatments studied
Part of Hormones & metabolism, Mental health clinical trials.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 to 65 years old
- You drink at least 4 drinks per day (women) or 5 drinks per day (men) on average
- You have a body mass index (BMI) of 27 or higher
- You are willing to come to weekly clinic visits and take the study medication
- You are currently trying to cut down on your drinking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if tirzepatide, a once-weekly injection, can help reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. If you struggle with alcohol and have stable schizophrenia, this study may offer a new treatment option.
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
This study looks at how the medicine tirzepatide (often used for diabetes or weight loss) affects the way your body processes alcohol. It may help understand if taking this medicine changes how alcohol affects you, which could lead to better guidance for people who drink while using it.
This trial tests if tirzepatide (a weekly injection) can help reduce binge eating compared to a placebo or another medication (lisdexamfetamine dimesylate). It may be a good fit for people with moderate or severe binge eating disorder who also have a high body weight.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
This study tests a medication called tirzepatide (a once-weekly injection) to help teenagers with obesity and related health conditions lose weight. It aims to see if the drug is safe and effective for this age group.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.